News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
624,460 Results
Type
Article (58968)
Company Profile (187)
Press Release (565305)
Multimedia
Podcasts (54)
Webinars (14)
Section
Business (169756)
Career Advice (1838)
Deals (28974)
Drug Delivery (97)
Drug Development (65792)
Employer Resources (150)
FDA (14377)
Job Trends (13777)
News (285734)
Policy (28017)
Tag
Academia (2911)
Academic (2)
Accelerated approval (5)
Adcomms (15)
Allergies (80)
Alliances (47783)
ALS (80)
Alzheimer's disease (1326)
Antibody-drug conjugate (ADC) (110)
Approvals (14423)
Artificial intelligence (273)
Autoimmune disease (19)
Automation (16)
Bankruptcy (223)
Best Places to Work (11210)
BIOSECURE Act (13)
Biosimilars (90)
Biotechnology (109)
Bladder cancer (68)
Brain cancer (24)
Breast cancer (249)
Cancer (1999)
Cardiovascular disease (156)
Career advice (1551)
Career pathing (26)
CAR-T (134)
Cell therapy (380)
Cervical cancer (17)
Clinical research (52645)
Collaboration (822)
Compensation (210)
Complete response letters (10)
COVID-19 (2627)
CRISPR (41)
C-suite (218)
Cystic fibrosis (83)
Data (2008)
Decentralized trials (2)
Denatured (21)
Depression (43)
Diabetes (232)
Diagnostics (6382)
Digital health (20)
Diversity (7)
Diversity, equity & inclusion (36)
Drug discovery (115)
Drug pricing (105)
Drug shortages (15)
Duchenne muscular dystrophy (82)
Earnings (60990)
Editorial (31)
Employer branding (20)
Employer resources (130)
Events (99671)
Executive appointments (690)
FDA (15544)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (725)
Gene editing (85)
Generative AI (26)
Gene therapy (272)
GLP-1 (608)
Government (4639)
Grass and pollen (6)
Guidances (62)
Healthcare (18811)
Huntington's disease (15)
IgA nephropathy (20)
Immunology and inflammation (87)
Indications (29)
Infectious disease (2771)
Inflammatory bowel disease (120)
Inflation Reduction Act (10)
Influenza (54)
Intellectual property (82)
Interviews (331)
IPO (12936)
IRA (40)
Job creations (3009)
Job search strategy (1337)
Kidney cancer (6)
Labor market (29)
Layoffs (342)
Leadership (14)
Legal (5815)
Liver cancer (68)
Lung cancer (272)
Lymphoma (126)
Machine learning (7)
Management (52)
Manufacturing (270)
MASH (61)
Medical device (12680)
Medtech (12685)
Mergers & acquisitions (16575)
Metabolic disorders (591)
Multiple sclerosis (72)
NASH (15)
Neurodegenerative disease (76)
Neuropsychiatric disorders (18)
Neuroscience (1807)
NextGen: Class of 2025 (6511)
Non-profit (4833)
Now hiring (29)
Obesity (306)
Opinion (195)
Ovarian cancer (66)
Pain (73)
Pancreatic cancer (75)
Parkinson's disease (133)
Partnered (21)
Patents (192)
Patient recruitment (105)
Peanut (44)
People (50656)
Pharmaceutical (52)
Pharmacy benefit managers (17)
Phase I (16599)
Phase II (22344)
Phase III (17604)
Pipeline (1115)
Policy (131)
Postmarket research (2420)
Preclinical (7793)
Press Release (69)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (231)
Rare diseases (321)
Real estate (5484)
Recruiting (61)
Regulatory (19448)
Reports (33)
Research institute (2607)
Resumes & cover letters (261)
Rett syndrome (5)
RNA editing (3)
RSV (38)
Schizophrenia (65)
Series A (124)
Series B (79)
Service/supplier (16)
Sickle cell disease (53)
Special edition (15)
Spinal muscular atrophy (131)
Sponsored (32)
Startups (3232)
State (1)
Stomach cancer (6)
Supply chain (58)
Tariffs (33)
The Weekly (32)
Vaccines (707)
Venture capitalists (31)
Weight loss (181)
Women's health (34)
Worklife (14)
Date
Today (166)
Last 7 days (795)
Last 30 days (2344)
Last 365 days (29643)
2025 (9815)
2024 (31772)
2023 (35935)
2022 (46903)
2021 (51321)
2020 (50725)
2019 (45175)
2018 (33953)
2017 (28684)
2016 (29244)
2015 (34597)
2014 (27239)
2013 (23818)
2012 (24310)
2011 (24988)
2010 (23152)
Location
Africa (831)
Alabama (55)
Alaska (6)
Arizona (181)
Arkansas (13)
Asia (40864)
Australia (6895)
California (5209)
Canada (1835)
China (464)
Colorado (254)
Connecticut (272)
Delaware (139)
Europe (84924)
Florida (835)
Georgia (203)
Hawaii (1)
Idaho (56)
Illinois (508)
India (28)
Indiana (309)
Iowa (10)
Japan (159)
Kansas (90)
Kentucky (23)
Louisiana (12)
Maine (70)
Maryland (808)
Massachusetts (3950)
Michigan (229)
Minnesota (359)
Mississippi (2)
Missouri (89)
Montana (31)
Nebraska (24)
Nevada (56)
New Hampshire (62)
New Jersey (1621)
New Mexico (31)
New York (1601)
North Carolina (927)
North Dakota (9)
Northern California (2279)
Ohio (190)
Oklahoma (14)
Oregon (31)
Pennsylvania (1237)
Puerto Rico (8)
Rhode Island (31)
South America (1064)
South Carolina (23)
South Dakota (1)
Southern California (1960)
Tennessee (97)
Texas (771)
United States (20733)
Utah (179)
Virginia (141)
Washington D.C. (60)
Washington State (520)
West Virginia (3)
Wisconsin (61)
624,460 Results for "quintiles hrs formerly health research solutions pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Deals
Sentrex Health Solutions Inc. Expands Innovative Healthcare Services with Strategic Acquisition of PerCuro Clinical Research Ltd.
Sentrex Health Solutions Inc., a leading provider of specialty healthcare services in Canada, is excited to announce the acquisition of PerCuro Clinical Research Ltd.—one of Canada’s premier providers of infusion services, clinical research, and advanced nursing care.
February 12, 2024
·
2 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Press Releases
Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego
May 1, 2025
·
3 min read
Press Releases
Fellow Health to Present Innovative Research on Prostate Cancer Biomarkers and PVSA Testing at AUA 2025
April 28, 2025
·
3 min read
Press Releases
GI Alliance and Iterative Health Partner to Advance GI Clinical Research in the Community
April 23, 2025
·
3 min read
Press Releases
Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research
April 16, 2025
·
2 min read
Press Releases
Integrated DNA Technologies Introduces Transformative Hybridization Capture Solution to Accelerate Cancer Research
April 21, 2025
·
3 min read
Press Releases
Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
April 24, 2025
·
5 min read
1 of 62,446
Next
